Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Versatility: Suitable for both clinical settings and at-home use for individuals managing injections
Description: Sitagliptin 100mg + Metformin 1000mg Sustained Release (SR) is a combination oral anti-diabetic medication used for the management of Type 2 Diabetes Mellitus in adults
Spadaro, A., Scott, K
of those participants, 231 completed their assigned treatment
To be considered for Wegovy on the NHS , you usually need: a BMI of 35 or higher (or 32.5 for some ethnic groups) at least one weight-related health condition Weight-related health conditions may include: type 2 diabetes high blood pressure high cholesterol heart disease obstructive sleep apnoea Before medication is considered, people are usually asked to try lifestyle changes , like improving their diet and increasing physical activity
